How Indivior Pharmaceuticals, Inc. stacks up

INDV · against 588 other Healthcare companies listed in US-listed

Valuation

85/ 100

Near the top of its peers.

Ranked #35 of 589 · scores higher than 94% of peers

Bars: peers in each 10-point band of the valuation score

27 peers with a valuation score of 80–89, including INDV · Click a bar to see the companies

Why valuation scores 85?

Weighted metrics compared with all Healthcare companies.

Mainly thanks to its earnings yield and EBITDA yield, which are stronger than most Healthcare peers.

Negative (a loss or cash outflow), so it counts as zero whatever the share price. Free cash flow yield: -2.6% vs peer median 0.0%
more operating profit (EBITDA) for the company's total value: stronger than 86% of peers. EBITDA yield: 9.5% vs peer median 4.0%
higher earnings for the price paid: stronger than 90% of peers. Earnings yield: 8.3% vs peer median 1.5%

Metric by metric

Position: dot = INDV, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.

Metric	INDV	Peer median	Better than	Weight
Earnings yieldHigher is better · 577 reported	7.7%	-4.3%	95%	30%
EBITDA yieldHigher is better · 578 reported	12.6%	-0.8%	91%	50%
Free cash flow yieldHigher is better · 553 reported	-2.6%	-2.3%	48%	20%
Book yieldHigher is better · 587 reported	-4.9%	25.9%	6%	Context only

Ranking by valuation score

Top 5 and the companies ranked around INDV

Rank	Company	Market cap	Valuation	Overall
1	Clinuvel Pharmaceuticals LimitedCUVL · US-listed	256M USD	98	80
2	Arbutus Biopharma CorporationABUS · US-listed	595M USD	96	97
2	CorMedix Inc.CRMD · US-listed	433M USD	96	81
2	Community Health Systems, Inc.CYH · US-listed	289M USD	96	57
2	InMode Ltd.INMD · US-listed	810M USD	96	69
⋯
32	Organigram Global Inc.OGI · US-listed	133M USD	88	51
32	SanofiSNY · US-listed	108.6B USD	88	66
34	GSK plcGSK · US-listed	97.5B USD	87	67
35	Amphastar Pharmaceuticals, Inc.AMPH · US-listed	1.2B USD	85	52
35	Indivior Pharmaceuticals, Inc.INDV · US-listed	4.3B USD	85	69
35	Organon & Co.OGN · US-listed	3.6B USD	85	43
38	Medline Inc.MDLN · US-listed	45.9B USD	84	61
38	Phibro Animal Health CorporationPAHC · US-listed	1.5B USD	84	65
40	AnaptysBio, Inc.ANAB · US-listed	1.4B USD	83	73

Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score

Bringing the fundamentals into focus…